U.S.: FDA decides against controversial breast cancer drug
- 6-0 vote to take the breast cancer indication off Avastin source
- » Even though lots of people liked the drug, the FDA has decided that it shouldn’t be used to treat breast cancer. However, European regulators allowed its use (as long as it was with another drug) at essentially the same time — which begs the question, why would the FDA be taking a drug off the market that so many people felt so passionate about?